Cargando…
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study
We aimed to overcome intratumoral heterogeneity in clear cell renal cell carcinoma (clearRCC). One hundred cases of clearRCC were sampled. First, usual standard sampling was applied (1 block/cm of tumor); second, the whole tumor was sampled, and 0.6 mm cores were taken from each block to construct a...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147893/ https://www.ncbi.nlm.nih.gov/pubmed/35629151 http://dx.doi.org/10.3390/jpm12050727 |
_version_ | 1784716919209721856 |
---|---|
author | Brunelli, Matteo Martignoni, Guido Malpeli, Giorgio Volpe, Alessandro Cima, Luca Raspollini, Maria Rosaria Barbareschi, Mattia Tafuri, Alessandro Masi, Giulia Barzon, Luisa Ammendola, Serena Villanova, Manuela Cerruto, Maria Angela Milella, Michele Buti, Sebastiano Bersanelli, Melissa Fornarini, Giuseppe Rebuzzi, Sara Elena Vellone, Valerio Gaetano Gaggero, Gabriele Procopio, Giuseppe Verzoni, Elena Bracarda, Sergio Fanelli, Martina Sabbatini, Roberto Passalacqua, Rodolfo Perrucci, Bruno Giganti, Maria Olga Donini, Maddalena Panni, Stefano Tucci, Marcello Prati, Veronica Ortega, Cinzia Caliò, Anna Eccher, Albino Alongi, Filippo Pappagallo, Giovanni Iacovelli, Roberto Mosca, Alessandra Umari, Paolo Montagnani, Ilaria Gobbo, Stefano Atzori, Francesco Munari, Enrico Maruzzo, Marco Basso, Umberto Pierconti, Francesco Patriarca, Carlo Colombo, Piergiuseppe Lapini, Alberto Conti, Giario Salvioni, Roberto Bollito, Enrico Cossarizza, Andrea Massari, Francesco Rizzo, Mimma Franco, Renato Zito-Marino, Federica Aberasturi Plata, Yoseba Galuppini, Francesca Sbaraglia, Marta Fassan, Matteo Dei Tos, Angelo Paolo Colecchia, Maurizio Moch, Holger Scaltriti, Maurizio Porta, Camillo Delahunt, Brett Giannarini, Gianluca Bortolus, Roberto Rescigno, Pasquale Banna, Giuseppe Luigi Signori, Alessio Obispo, Miguel Angel Llaja Perris, Roberto Antonelli, Alessandro |
author_facet | Brunelli, Matteo Martignoni, Guido Malpeli, Giorgio Volpe, Alessandro Cima, Luca Raspollini, Maria Rosaria Barbareschi, Mattia Tafuri, Alessandro Masi, Giulia Barzon, Luisa Ammendola, Serena Villanova, Manuela Cerruto, Maria Angela Milella, Michele Buti, Sebastiano Bersanelli, Melissa Fornarini, Giuseppe Rebuzzi, Sara Elena Vellone, Valerio Gaetano Gaggero, Gabriele Procopio, Giuseppe Verzoni, Elena Bracarda, Sergio Fanelli, Martina Sabbatini, Roberto Passalacqua, Rodolfo Perrucci, Bruno Giganti, Maria Olga Donini, Maddalena Panni, Stefano Tucci, Marcello Prati, Veronica Ortega, Cinzia Caliò, Anna Eccher, Albino Alongi, Filippo Pappagallo, Giovanni Iacovelli, Roberto Mosca, Alessandra Umari, Paolo Montagnani, Ilaria Gobbo, Stefano Atzori, Francesco Munari, Enrico Maruzzo, Marco Basso, Umberto Pierconti, Francesco Patriarca, Carlo Colombo, Piergiuseppe Lapini, Alberto Conti, Giario Salvioni, Roberto Bollito, Enrico Cossarizza, Andrea Massari, Francesco Rizzo, Mimma Franco, Renato Zito-Marino, Federica Aberasturi Plata, Yoseba Galuppini, Francesca Sbaraglia, Marta Fassan, Matteo Dei Tos, Angelo Paolo Colecchia, Maurizio Moch, Holger Scaltriti, Maurizio Porta, Camillo Delahunt, Brett Giannarini, Gianluca Bortolus, Roberto Rescigno, Pasquale Banna, Giuseppe Luigi Signori, Alessio Obispo, Miguel Angel Llaja Perris, Roberto Antonelli, Alessandro |
author_sort | Brunelli, Matteo |
collection | PubMed |
description | We aimed to overcome intratumoral heterogeneity in clear cell renal cell carcinoma (clearRCC). One hundred cases of clearRCC were sampled. First, usual standard sampling was applied (1 block/cm of tumor); second, the whole tumor was sampled, and 0.6 mm cores were taken from each block to construct a tissue microarray; third, the residual tissue, mapped by taking pieces 0.5 × 0.5 cm, reconstructed the entire tumor mass. Precisely, six randomly derived pieces of tissues were placed in each cassette, with the number of cassettes being based on the diameter of the tumor (called multisite 3D fusion). Angiogenic and immune markers were tested. Routine 5231 tissue blocks were obtained. Multisite 3D fusion sections showed pattern A, homogeneous high vascular density (10%), pattern B, homogeneous low vascular density (8%) and pattern C, heterogeneous angiogenic signatures (82%). PD-L1 expression was seen as diffuse (7%), low (33%) and absent (60%). Tumor-infiltrating CD8 scored high in 25% (pattern hot), low in 65% (pattern weak) and zero in 10% of cases (pattern desert). Grading was upgraded in 26% of cases (G3–G4), necrosis and sarcomatoid/rhabdoid characters were observed in, respectively, 11 and 7% of cases after 3D fusion (p = 0.03). CD8 and PD-L1 immune expressions were higher in the undifferentiated G4/rhabdoid/sarcomatoid clearRCC subtypes (p = 0.03). Again, 22% of cases were set to intermediate to high risk of clinical recurrence due to new morphological findings of all aggressive G4, sarcomatoid/rhabdoid features by using 3D fusion compared to standard methods (p = 0.04). In conclusion, we propose an easy-to-apply multisite 3D fusion sampling that negates bias due to tumor heterogeneity. |
format | Online Article Text |
id | pubmed-9147893 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91478932022-05-29 Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study Brunelli, Matteo Martignoni, Guido Malpeli, Giorgio Volpe, Alessandro Cima, Luca Raspollini, Maria Rosaria Barbareschi, Mattia Tafuri, Alessandro Masi, Giulia Barzon, Luisa Ammendola, Serena Villanova, Manuela Cerruto, Maria Angela Milella, Michele Buti, Sebastiano Bersanelli, Melissa Fornarini, Giuseppe Rebuzzi, Sara Elena Vellone, Valerio Gaetano Gaggero, Gabriele Procopio, Giuseppe Verzoni, Elena Bracarda, Sergio Fanelli, Martina Sabbatini, Roberto Passalacqua, Rodolfo Perrucci, Bruno Giganti, Maria Olga Donini, Maddalena Panni, Stefano Tucci, Marcello Prati, Veronica Ortega, Cinzia Caliò, Anna Eccher, Albino Alongi, Filippo Pappagallo, Giovanni Iacovelli, Roberto Mosca, Alessandra Umari, Paolo Montagnani, Ilaria Gobbo, Stefano Atzori, Francesco Munari, Enrico Maruzzo, Marco Basso, Umberto Pierconti, Francesco Patriarca, Carlo Colombo, Piergiuseppe Lapini, Alberto Conti, Giario Salvioni, Roberto Bollito, Enrico Cossarizza, Andrea Massari, Francesco Rizzo, Mimma Franco, Renato Zito-Marino, Federica Aberasturi Plata, Yoseba Galuppini, Francesca Sbaraglia, Marta Fassan, Matteo Dei Tos, Angelo Paolo Colecchia, Maurizio Moch, Holger Scaltriti, Maurizio Porta, Camillo Delahunt, Brett Giannarini, Gianluca Bortolus, Roberto Rescigno, Pasquale Banna, Giuseppe Luigi Signori, Alessio Obispo, Miguel Angel Llaja Perris, Roberto Antonelli, Alessandro J Pers Med Article We aimed to overcome intratumoral heterogeneity in clear cell renal cell carcinoma (clearRCC). One hundred cases of clearRCC were sampled. First, usual standard sampling was applied (1 block/cm of tumor); second, the whole tumor was sampled, and 0.6 mm cores were taken from each block to construct a tissue microarray; third, the residual tissue, mapped by taking pieces 0.5 × 0.5 cm, reconstructed the entire tumor mass. Precisely, six randomly derived pieces of tissues were placed in each cassette, with the number of cassettes being based on the diameter of the tumor (called multisite 3D fusion). Angiogenic and immune markers were tested. Routine 5231 tissue blocks were obtained. Multisite 3D fusion sections showed pattern A, homogeneous high vascular density (10%), pattern B, homogeneous low vascular density (8%) and pattern C, heterogeneous angiogenic signatures (82%). PD-L1 expression was seen as diffuse (7%), low (33%) and absent (60%). Tumor-infiltrating CD8 scored high in 25% (pattern hot), low in 65% (pattern weak) and zero in 10% of cases (pattern desert). Grading was upgraded in 26% of cases (G3–G4), necrosis and sarcomatoid/rhabdoid characters were observed in, respectively, 11 and 7% of cases after 3D fusion (p = 0.03). CD8 and PD-L1 immune expressions were higher in the undifferentiated G4/rhabdoid/sarcomatoid clearRCC subtypes (p = 0.03). Again, 22% of cases were set to intermediate to high risk of clinical recurrence due to new morphological findings of all aggressive G4, sarcomatoid/rhabdoid features by using 3D fusion compared to standard methods (p = 0.04). In conclusion, we propose an easy-to-apply multisite 3D fusion sampling that negates bias due to tumor heterogeneity. MDPI 2022-04-30 /pmc/articles/PMC9147893/ /pubmed/35629151 http://dx.doi.org/10.3390/jpm12050727 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Brunelli, Matteo Martignoni, Guido Malpeli, Giorgio Volpe, Alessandro Cima, Luca Raspollini, Maria Rosaria Barbareschi, Mattia Tafuri, Alessandro Masi, Giulia Barzon, Luisa Ammendola, Serena Villanova, Manuela Cerruto, Maria Angela Milella, Michele Buti, Sebastiano Bersanelli, Melissa Fornarini, Giuseppe Rebuzzi, Sara Elena Vellone, Valerio Gaetano Gaggero, Gabriele Procopio, Giuseppe Verzoni, Elena Bracarda, Sergio Fanelli, Martina Sabbatini, Roberto Passalacqua, Rodolfo Perrucci, Bruno Giganti, Maria Olga Donini, Maddalena Panni, Stefano Tucci, Marcello Prati, Veronica Ortega, Cinzia Caliò, Anna Eccher, Albino Alongi, Filippo Pappagallo, Giovanni Iacovelli, Roberto Mosca, Alessandra Umari, Paolo Montagnani, Ilaria Gobbo, Stefano Atzori, Francesco Munari, Enrico Maruzzo, Marco Basso, Umberto Pierconti, Francesco Patriarca, Carlo Colombo, Piergiuseppe Lapini, Alberto Conti, Giario Salvioni, Roberto Bollito, Enrico Cossarizza, Andrea Massari, Francesco Rizzo, Mimma Franco, Renato Zito-Marino, Federica Aberasturi Plata, Yoseba Galuppini, Francesca Sbaraglia, Marta Fassan, Matteo Dei Tos, Angelo Paolo Colecchia, Maurizio Moch, Holger Scaltriti, Maurizio Porta, Camillo Delahunt, Brett Giannarini, Gianluca Bortolus, Roberto Rescigno, Pasquale Banna, Giuseppe Luigi Signori, Alessio Obispo, Miguel Angel Llaja Perris, Roberto Antonelli, Alessandro Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study |
title | Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study |
title_full | Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study |
title_fullStr | Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study |
title_full_unstemmed | Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study |
title_short | Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study |
title_sort | validation of a novel three-dimensional (3d fusion) gross sampling protocol for clear cell renal cell carcinoma to overcome intratumoral heterogeneity: the meet-uro 18 study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147893/ https://www.ncbi.nlm.nih.gov/pubmed/35629151 http://dx.doi.org/10.3390/jpm12050727 |
work_keys_str_mv | AT brunellimatteo validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT martignoniguido validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT malpeligiorgio validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT volpealessandro validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT cimaluca validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT raspollinimariarosaria validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT barbareschimattia validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT tafurialessandro validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT masigiulia validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT barzonluisa validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT ammendolaserena validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT villanovamanuela validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT cerrutomariaangela validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT milellamichele validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT butisebastiano validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT bersanellimelissa validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT fornarinigiuseppe validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT rebuzzisaraelena validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT vellonevaleriogaetano validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT gaggerogabriele validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT procopiogiuseppe validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT verzonielena validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT bracardasergio validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT fanellimartina validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT sabbatiniroberto validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT passalacquarodolfo validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT perruccibruno validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT gigantimariaolga validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT doninimaddalena validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT pannistefano validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT tuccimarcello validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT prativeronica validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT ortegacinzia validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT calioanna validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT eccheralbino validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT alongifilippo validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT pappagallogiovanni validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT iacovelliroberto validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT moscaalessandra validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT umaripaolo validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT montagnaniilaria validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT gobbostefano validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT atzorifrancesco validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT munarienrico validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT maruzzomarco validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT bassoumberto validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT piercontifrancesco validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT patriarcacarlo validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT colombopiergiuseppe validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT lapinialberto validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT contigiario validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT salvioniroberto validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT bollitoenrico validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT cossarizzaandrea validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT massarifrancesco validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT rizzomimma validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT francorenato validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT zitomarinofederica validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT aberasturiplatayoseba validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT galuppinifrancesca validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT sbaragliamarta validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT fassanmatteo validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT deitosangelopaolo validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT colecchiamaurizio validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT mochholger validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT scaltritimaurizio validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT portacamillo validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT delahuntbrett validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT giannarinigianluca validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT bortolusroberto validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT rescignopasquale validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT bannagiuseppeluigi validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT signorialessio validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT obispomiguelangelllaja validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT perrisroberto validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study AT antonellialessandro validationofanovelthreedimensional3dfusiongrosssamplingprotocolforclearcellrenalcellcarcinomatoovercomeintratumoralheterogeneitythemeeturo18study |